Kennedy Capital Management, Inc. Exagen Inc. Transaction History
Kennedy Capital Management, Inc.
- $4.23 Billion
- Q4 2024
A detailed history of Kennedy Capital Management, Inc. transactions in Exagen Inc. stock. As of the latest transaction made, Kennedy Capital Management, Inc. holds 184,473 shares of XGN stock, worth $708,376. This represents 0.02% of its overall portfolio holdings.
Number of Shares
184,473
Previous 169,553
8.8%
Holding current value
$708,376
Previous $523,000
44.55%
% of portfolio
0.02%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding XGN
# of Institutions
43Shares Held
6.05MCall Options Held
1.1KPut Options Held
6.4K-
Rtw Investments, LP New York, NY1.51MShares$5.81 Million0.1% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A6891KShares$3.42 Million0.01% of portfolio
-
Silvercrest Asset Management Group LLC New York, NY535KShares$2.05 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA491KShares$1.89 Million0.0% of portfolio
-
Morgan Stanley New York, NY484KShares$1.86 Million0.0% of portfolio
About EXAGEN INC.
- Ticker XGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 16,260,400
- Market Cap $62.4M
- Description
- Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...